Abstract:'Dysarthria' is a group of motor speech disorders resulting from a disturbance in neuromuscular control. Most individuals with dysarthria cope with communicative restrictions due to speech impairments and reduced intelligibility. Thus, language-sensitive measurements of intelligibility are important in dysarthria neurological assessment. The Frenchay Dysarthria Assessment, 2nd edition (FDA-2), is a validated tool for the identification of the nature and patterns of oro-motor movements associated with different types of dysarthria. The current study conducted a careful culture- and linguistic-sensitive adaption of the two intelligibility subtests of the FDA-2 to Hebrew (words and sentences) and performed a preliminary validation with relevant clinical populations. First, sets of Hebrew words and sentences were constructed, based on the criteria defined in FDA-2, as well as on several other factors that may affect performance: emotional valence, arousal and familiarity. Second, the new subtests were validated in healthy older adults (n = 20), and in two clinical groups (acquired dysarthria, n = 15; and developmental dysarthria, n = 19). Analysis indicated that the new subtests were found to be specific and sensitive, valid and reliable, as scores significantly differ between healthy older adults and adults with dysarthria, correlated with other subjective measures of intelligibility, and showed high test-retest reliability. The words and sentences intelligibility subtests can be used to evaluate speech disorders in various populations of Hebrew speakers, thus may be an important addition to the speech-language pathologist's toolbox, for clinical work as well as for research purposes. WHAT THIS PAPER ADDS: What is already known on the subject 'Dysarthria' is a group of disorders reflecting impairments in the strength, speed and precision of movements required for adequate control of the various speech subsystems. Reduced speech intelligibility is one of the main consequences of all dysarthria subtypes, irrespective of their underlying cause. Indeed, most individuals with dysarthria cope with communicative restrictions due to speech impairments. Thus, language-sensitive measurements of intelligibility are important in dysarthria assessment. The FDA-2's words and sentences subtests present standardized and validated tools for the identification of the nature and patterns of oro-motor movements associated with different types of dysarthria. What this paper adds to existing knowledge The lack of assessment tools in Hebrew poses challenges to clinical evaluation as well as research purposes. The current study conducted a careful culture- and linguistic-sensitive adaption of the FDA-2 intelligibility subtests to Hebrew and performed a preliminary validation with relevant clinical populations. First, sets of Hebrew words and sentences were constructed, based on the criteria defined in FDA-2, as well as on several other factors that may affect performance: emotional valence, arousal and familiarity. Second, the new subtests were validated in healthy older adults (n = 20), and in two clinical groups (adults with acquired dysarthria, n = 15; and young adults with developmental dysarthria, n = 19). What are the potential or actual clinical implications of this work? Analyses indicated that the new word and sentence subtests are specific, sensitive, valid and reliable. Namely, (1) they successfully differentiate between healthy individuals and individuals with dysarthria; (2) they correlate with other subjective measures of intelligibility; and (3) they show high test-retest reliability. The words and sentences intelligibility subtests can be used to evaluate speech disorders in various populations of Hebrew speakers. Thus, they may be an important addition to the speech-language pathologist's toolbox, for clinical and research purposes. The methods described here can be emulated for the adaptation of speech assessment tools to other languages.

Guidelines and recommendations for cross-linguistic aphasia assessment: a review of 10 years of comprehensive aphasia test adaptations

Cross-linguistic adaptations of The Comprehensive Aphasia Test: Challenges and solutions

Invaluable Benefits of 10 Years of the International Collaboration of Aphasia Trialists (CATs)

Linguistic and cultural properties of the Spanish adaptation of the CAT (SP-CAT): pilot results from neurotypical subjects

"Communicative competence assessment of the person with aphasia caregiver: Standardization of the ACCA-CHECKLIST"

Cross-cultural adaptation process of the "Conversation Analysis Profile for People with Aphasia" to the Portuguese language

Cross-Linguistic and Multicultural Considerations in Evaluating Bilingual Adults With Aphasia

Cultural adaptation and psychometric analysis of Communication Activities of Daily Living third edition in Spanish and Catalan for people with aphasia

Adaptation and validation of the Greek version of the Communication and Language Assessment questionnaire for persons with Multiple Sclerosis (CLAMS)

Telehealth practice in aphasia: A survey of UK speech and language therapists, with a focus on assessment

Comprehensive quality assessment for aphasia rehabilitation after stroke: protocol for a multicentre, mixed-methods study

A Chinese Version of the Language Screening Test (CLAST) for Early-Stage Stroke Patients.

Using a translanguaging framework to examine language production in a trilingual person with aphasia

An updated systematic review of stroke clinical practice guidelines to inform aphasia management

The Western Aphasia Battery: a systematic review of research and clinical applications

Neuropsychological application of the International Test Commission Guidelines for Translation and Adapting of Tests

162: BRISBANE EVIDENCE-BASED LANGUAGE TEST, BRISBANE EBLT: A NEW DIAGNOSTIC TEST FOR THE IDENTIFICATION OF ACUTE POST-STROKE LANGUAGE DISORDERS

Tools for Assessing Quality of Life in People with Stroke-Induced Aphasia: A Literature Review

'But I have a cat, I have to talk to her now: a qualitative study on reasons for not participating in guideline-based aphasia therapy from the perspective of patients in German-speaking countries

The challenges and facilitators to successful translation and adaptation of written self-report psychological measures into sign languages: A systematic review.

Validation and cross-linguistic adaptation of the Frenchay Dysarthria Assessment (FDA-2) speech intelligibility tests: Hebrew version